Reslizumab in gastroenterology: Experience in a patient with eosinophilic gastroenteritis
Gastroenterol Hepatol. 2022 Apr:45 Suppl 1:147-148.
doi: 10.1016/j.gastrohep.2021.11.002.
Epub 2021 Nov 10.
[Article in
English,
Spanish]
Affiliations
- 1 Unidad de Gestión Clínica de Enfermedades Digestivas, Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, Cádiz, España. Electronic address: alegama91@hotmail.com.
- 2 Unidad de Gestión Clínica de Enfermedades Digestivas, Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, Cádiz, España.
No abstract available
MeSH terms
-
Anti-Asthmatic Agents*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Enteritis
-
Eosinophilia* / complications
-
Eosinophilia* / drug therapy
-
Gastritis
-
Gastroenterology*
-
Humans
Substances
-
Anti-Asthmatic Agents
-
Antibodies, Monoclonal, Humanized
-
reslizumab